Improvement of Chronic Spontaneous Urticaria After Glucagon-Like Peptide 1 Receptor Agonist Therapy: Report of Two Cases
Abstract Chronic spontaneous urticaria (CSU) is a mast cell-driven disease that affects approximately 1% of the population. Second-generation non-sedating H1-antihistamines (H1AH) are considered the first-line treatment; however, a substantial proportion of patients remain refractory and require alt...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Adis, Springer Healthcare
2026-01-01
|
| سلاسل: | Dermatology and Therapy |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1007/s13555-025-01640-7 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|